WHO ICTRP trial
Influence of new guidelines for the therapy of antiphospholipid syndrome
DRKS00035485 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00035485 |
|---|---|
| Public title | Influence of new guidelines for the therapy of antiphospholipid syndrome |
| Scientific title | Influence of new guidelines for the therapy of antiphospholipid syndrome - APS_IIT |
| Primary sponsor | Universitätsklinikum Frankfurt, Hämophiliezentrum |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | D68.6;Other thrombophilia |
| Interventions | Group 1: Patients with confirmed antiphospholipid syndrome: classification and course of therapy, followup regarding reccurrences, thrombotic events, pregnancies by structured phone interview |
| Registration date | Apr 28, 2025 |
| Target size | 400 |
| Secondary IDs | 2025-2265 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: